Corcept Therapeutics Inc’s recently made public that its Officer Lyon Joseph Douglas acquired Company’s shares for reported $0.34 million on Aug 01 ’25. In the deal valued at $67.17 per share,5,000 shares were bought.
Then, Maduck Sean bought 20,000 shares, generating $1,343,000 in total proceeds.
Before that, BELANOFF JOSEPH K bought 615 shares. Corcept Therapeutics Inc shares valued at $41,310 were divested by the Officer at a price of $67.17 per share.
Truist upgraded its Corcept Therapeutics Inc [CORT] rating to a Buy from a a Hold in a research note published on November 06, 2023; the price target was increased to $38 from $29. A number of analysts have revised their coverage, including SVB Securities’s analysts, who began to cover the stock in mid April with a ‘”a Market perform”‘ rating. Piper Sandler began covering CORT with “an Overweight” recommendation on April 04, 2023. Jefferies revised its rating on February 15, 2023. It rated CORT as “a Hold” which previously was an “a Buy”.
Price Performance Review of CORT
On Monday, Corcept Therapeutics Inc [NASDAQ:CORT] saw its stock jump 4.01% to $71.77. Over the last five days, the stock has gained 3.79%. Corcept Therapeutics Inc shares have risen nearly 85.60% since the year began. Nevertheless, the stocks have risen 42.43% over the past one year.
How much short interest is there in Corcept Therapeutics Inc?
A steep rise in short interest was recorded in Corcept Therapeutics Inc stocks on 2025-07-15, dropping by -1.43 million shares to a total of 11.22 million shares. Yahoo Finance data shows the prior-month short interest on 2025-06-13 was 12.65 million shares. There was a decline of -12.73%, which implies that there is a negative sentiment for the stock.
